Cryptic Rearrangement of the KMT2A Gene in a B-cell Acute Lymphoblastic Leukemia
Anticancer Research · 2025
DOI: 10.21873/anticanres.17479 ↗Kurz gefasst
Fallbericht in der Zeitschrift Anticancer Research, 2025. Verfasst von Marta Brunetti und 5 weiteren Autor:innen. Beteiligte Einrichtung: Section for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway. Hauptthemen laut MEDLINE: Myeloid-Lymphoid Leukemia Protein, Histone-Lysine N-Methyltransferase, Gene Rearrangement, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Section for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.
- Department of Pathology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.
- Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
- Department of Haematology, Oslo University Hospital, Riks Hospital, Oslo, Norway.
Zitieren
APA
Brunetti, M., Andersen, K., Spetalen, S., Tjønnfjord, G. E., Heim, S., & Micci, F. (2025). Cryptic Rearrangement of the KMT2A Gene in a B-cell Acute Lymphoblastic Leukemia. Anticancer Research. https://doi.org/10.21873/anticanres.17479
Vancouver
Brunetti M, Andersen K, Spetalen S, Tjønnfjord GE, Heim S, Micci F. Cryptic Rearrangement of the KMT2A Gene in a B-cell Acute Lymphoblastic Leukemia. Anticancer Research. 2025. doi:10.21873/anticanres.17479
BibTeX
@article{Brunetti2025,
author = {Brunetti, Marta and Andersen, Kristin and Spetalen, Signe and Tjønnfjord, Geir E and Heim, Sverre and Micci, Francesca},
title = {Cryptic Rearrangement of the KMT2A Gene in a B-cell Acute Lymphoblastic Leukemia},
journal = {Anticancer Research},
year = {2025},
doi = {10.21873/anticanres.17479}
}
EUVIMED